“…Studies including patients who recovered from COVID-19 reported increased [4,27,28,33,35,36], slightly increased [29,32,38,39,41] or similar [31,34] T1 native mapping values compared to controls. In particular, Kotecha et al [28], Puntmann et al [35], and Thornton et al [37] found significantly higher T1 native mapping values in large groups of recovered subjects (148, 100 and 90, respectively) compared to different control groups, including patients without myocardial injury, healthy volunteers or controls, and risk factor-matched controls [26,28,35,37]. In addition, patients who recovered from COVID-19 and had MIS-myocarditis had higher T1 native values than those with non-MIS myocarditis [30].…”